tradingkey.logo
搜索

Prelude Therapeutics Inc

PRLD
添加自选
4.600USD
-0.450-8.91%
收盘 07-31 16:00美东报价延迟15分钟
366.37M总市值
亏损市盈率 TTM

PRLD 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Prelude Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Prelude Therapeutics Inc财报日历

最新发布
5月 12, 2026
每股收益 / 预测值
-0.13/-0.25
营业收入 / 预测值
4.58M/0.00
报告期
FY2025 财报
营业收入(YoY)
12.14M
73.43%
每股收益(YoY)
-1.29
22.93%
分析师评级
BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
70.20%-0.13
45.48%-0.21
39.10%-0.26
10.37%-0.41
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
---0.45
---0.54
---0.58
---0.60
---1.84
----
----
----
----
----
营业收入
--4.58M
41.00%5.64M
116.67%6.50M
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
净利润
67.63%-10.38M
42.72%-16.46M
38.88%-19.73M
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
利润率
---226.75%
59.38%-291.79%
71.79%-303.46%
----
----
---718.27%
---1075.70%
----
----
----
----
----
----
----
----
----
----
----
----
----
毛利率
--100.00%
0.00%100.00%
0.00%100.00%
----
----
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
资产负债率
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
--0.04%
--0.12%
--0.18%
--0.23%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
营业收入
--4.58M
41.00%5.64M
116.67%6.50M
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
营业利润
59.03%-14.18M
48.72%-17.35M
40.60%-20.42M
13.37%-32.19M
-0.77%-34.61M
9.49%-33.83M
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-11.96%-37.38M
-9.80%-33.38M
-9.97%-32.40M
3.87%-29.11M
-1.14%-33.38M
1.39%-30.41M
-5.51%-29.46M
-37.88%-30.29M
-69.75%-33.01M
-69.95%-30.84M
---27.92M
净利润
67.63%-10.38M
42.72%-16.46M
38.88%-19.73M
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
流动资产
-17.39%84.59M
-22.23%105.69M
-62.70%58.33M
-57.93%76.88M
-50.14%102.40M
-42.32%135.90M
-33.43%156.39M
-29.78%182.71M
17.18%205.37M
15.27%235.59M
3.54%234.92M
4.66%260.21M
-35.08%175.26M
-30.75%204.38M
-30.38%226.89M
-27.85%248.62M
-26.04%269.97M
33.65%295.12M
36.90%325.90M
1022.50%344.57M
流动负债总额
110.85%41.72M
106.68%52.99M
-18.15%18.19M
-10.40%20.91M
12.15%19.79M
17.46%25.64M
31.56%22.22M
53.62%23.34M
-10.27%17.64M
0.59%21.83M
-21.65%16.89M
-3.93%15.19M
22.36%19.66M
13.03%21.70M
9.65%21.56M
7.73%15.81M
29.34%16.07M
68.80%19.20M
73.11%19.66M
160.28%14.68M
总资产
-15.30%119.64M
-19.49%141.31M
-51.95%94.75M
-48.76%114.92M
-42.83%141.26M
-36.79%175.51M
-23.71%197.22M
-20.07%224.29M
24.60%247.11M
25.93%277.67M
6.68%258.51M
8.32%280.61M
-29.34%198.32M
-27.73%220.50M
-26.84%242.33M
-25.90%259.06M
-24.11%280.67M
36.45%305.10M
38.19%331.22M
967.52%349.58M
总负债
56.13%59.46M
64.97%72.68M
-11.20%36.22M
-6.99%39.08M
4.70%38.08M
8.58%44.06M
101.39%40.79M
126.48%42.02M
57.98%36.37M
61.89%40.58M
-18.72%20.25M
1.87%18.55M
22.08%23.02M
30.53%25.06M
24.76%24.92M
19.65%18.21M
42.18%18.86M
68.33%19.20M
75.62%19.98M
168.29%15.22M
总权益
-41.67%60.18M
-47.79%68.64M
-62.58%58.53M
-58.39%75.84M
-51.04%103.18M
-44.55%131.46M
-34.34%156.43M
-30.44%182.28M
20.22%210.73M
21.31%237.09M
9.59%238.26M
8.81%262.06M
-33.04%175.30M
-31.64%195.44M
-30.15%217.41M
-27.97%240.84M
-26.57%261.81M
34.74%285.90M
36.33%311.24M
1134.99%334.36M
经营净额
36.65%-21.68M
211.45%23.12M
29.97%-19.11M
-13.09%-26.07M
-7.68%-34.23M
12.02%-20.74M
-6.28%-27.30M
16.67%-23.06M
-5.50%-31.79M
-2.84%-23.58M
-25.66%-25.68M
-49.82%-27.67M
-37.63%-30.13M
10.80%-22.93M
6.13%-20.44M
7.25%-18.47M
-35.63%-21.89M
-73.11%-25.70M
-74.09%-21.77M
---19.91M
投资净额
-86.33%8.50M
-372.80%-60.34M
273.53%40.09M
-55.89%11.52M
99.18%62.19M
185.91%22.12M
-28.66%10.73M
134.63%26.12M
73.46%31.22M
470.92%7.74M
-30.37%15.04M
-539.01%-75.43M
-56.68%18.00M
175.11%1.35M
108.29%21.61M
4609.45%17.18M
4313.79%41.55M
-448.33%-1.80M
-153212.94%-260.63M
---381.00K
融资净额
-96.25%-314.00K
73464.71%24.94M
96.18%-5.00K
-37.29%37.00K
-1042.86%-160.00K
-100.13%-34.00K
-248.86%-131.00K
-99.95%59.00K
94.80%-14.00K
16181.94%25.24M
-40.54%88.00K
30913.65%111.34M
-275.82%-269.00K
-92.07%155.00K
-79.18%148.00K
-14.93%359.00K
-99.91%153.00K
249.50%1.95M
-99.67%711.00K
--422.00K

常见问题

Prelude Therapeutics Inc的总收入是多少?

根据Prelude Therapeutics Inc的FY2025财报,总收入达到了12.14M(同比变化7.00M)。

Prelude Therapeutics Inc的流动资产是多少?

根据Prelude Therapeutics Inc的FY2025财报,流动资产为105.69M(同比变化-22.23)。

Prelude Therapeutics Inc的总资产是多少?

根据Prelude Therapeutics Inc的FY2025财报,Prelude Therapeutics Inc的总资产为141.31M(同比变化-19.49)。

Prelude Therapeutics Inc的总负债是多少?

根据Prelude Therapeutics Inc的FY2025财报,Prelude Therapeutics Inc的总负债为72.68M(同比变化64.97)。

Prelude Therapeutics Inc的总权益是多少?

根据Prelude Therapeutics Inc的FY2025财报,Prelude Therapeutics Inc的总权益为68.64M(同比变化-47.79)。

Prelude Therapeutics Inc的净营业收入是多少?

根据Prelude Therapeutics Inc的FY2025财报,Prelude Therapeutics Inc的净营业收入为-104.57M(同比变化25.16)。

Prelude Therapeutics Inc的净投资是多少?

根据Prelude Therapeutics Inc的FY2025财报,Prelude Therapeutics Inc的净投资为53.46M(同比变化-40.73)。

Prelude Therapeutics Inc的净融资是多少?

根据Prelude Therapeutics Inc的FY2025财报,Prelude Therapeutics Inc的净融资为24.82M(同比变化20780.00)。

Prelude Therapeutics Inc的每股收益(EPS)是多少?

根据Prelude Therapeutics Inc的FY2025财报,每股收益(EPS)为-1.29(同比变化22.93)。

Prelude Therapeutics Inc的净利润是多少?

根据Prelude Therapeutics Inc的FY2025财报,净利润为-99.50M(同比变化21.76)。

Prelude Therapeutics Inc的净利润率是多少?

根据Prelude Therapeutics Inc的FY2025财报,净利润率为-819.59(同比变化54.89)。

Prelude Therapeutics Inc的股东权益回报率(ROE)是多少?

根据Prelude Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-99.45(同比变化-44.10)。

Prelude Therapeutics Inc的资产回报率(ROA)是多少?

根据Prelude Therapeutics Inc的FY2025财报,资产回报率(ROA)为-62.81(同比变化-11.91)。

Prelude Therapeutics Inc的营业利润是多少?

根据Prelude Therapeutics Inc的FY2025财报,营业利润为-104.57M(同比变化25.16)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有